Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

NCT00765817 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: placebo
DRUG: exenatide

Sponsor

AstraZeneca

Collaborators

[object Object]